Design of transgenes for efficient expression of active chimeric proteins on mammalian cells
- 27 March 2001
- journal article
- Published by Wiley in Biotechnology & Bioengineering
- Vol. 73 (4) , 313-323
- https://doi.org/10.1002/bit.1064
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Blockade of T Cell Activation Using a Surface-Linked Single-Chain Antibody to CTLA-4 (CD152)The Journal of Immunology, 2000
- Degradation of a Short-lived Glycoprotein from the Lumen of the Endoplasmic Reticulum: The Role of N-linked Glycans and the Unfolded Protein ResponseMolecular Biology of the Cell, 1999
- Expression of chimeric monomer and dimer proteins on the plasma membrane of mammalian cellsBiotechnology & Bioengineering, 1999
- Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrugBritish Journal of Cancer, 1999
- Costimulation by CD28 sFv expressed on the tumor cell surface or as a soluble bispecific molecule targeted to the L6 carcinoma antigenTissue Antigens, 1996
- Antigen‐specific targeting of CD28‐mediated T cell co‐stimulation using chimeric single‐chain antibody variable fragment‐CD28 receptorsEuropean Journal of Immunology, 1996
- Selective isolation of transiently transfected cells from a mammalian cell population with vectors expressing a membrane anchored single-chain antibodyJournal of Immunological Methods, 1996
- Intercellular transfer of a glycosylphosphatidylinositol (GPI)-linked protein: release and uptake of CD4-GPI from recombinant adeno-associated virus-transduced HeLa cells.Proceedings of the National Academy of Sciences, 1996
- New simplified molecular design for functional T cell receptorEuropean Journal of Immunology, 1993
- Endocytosis of the ASGP receptor H1 is reduced by mutation of tyrosine-5 but still occurs via coated pits.The Journal of cell biology, 1991